English

Eligibility Criteria

7 forms  
  1. StudyEvent: SEV1
    1. Eligibility Criteria
    2. Subject ID, subject source, source subject ID, consent group, and affection status of participants with or without lung cancer and involved in the "Transdisciplinary Research into Cancer of the Lung (TRICL) - Exome Plus Targeted Sequencing" project.
    3. Subject ID, sample ID, sample source, source sample ID, study accession, and sample use variable of participants with or without lung cancer and involved in the "Transdisciplinary Research into Cancer of the Lung (TRICL) - Exome Plus Targeted Sequencing" project.
    4. Sample ID, body site where sample was obtained, analyte type, type of DNA extraction, and tumor status of sample of participants with or without lung cancer and involved in the "Transdisciplinary Research into Cancer of the Lung (TRICL) - Exome Plus Targeted Sequencing" project.
    5. Subject ID, study site, gender, case or control status, age, smoking status, ethnicity, history, and cigarette pack per years of participants with or without lung cancer and involved in the "Transdisciplinary Research into Cancer of the Lung (TRICL) - Exome Plus Targeted Sequencing" project.
    6. Subject ID, age, gender, subjects with or without lung cancer, and smoking status of participants with or without lung cancer and involved in the "Transdisciplinary Research into Cancer of the Lung (TRICL) - Affymetrix" project.
    7. Sample ID, analyte type, body site where sample was obtained, tumor status of sample, tumor subtype of samples, and source repository where subjects originate of participants with or without lung cancer and involved in the "Transdisciplinary Research into Cancer of the Lung (TRICL) - Affymetrix" project.
Inclusion and exclusion criteria
Description

Inclusion and exclusion criteria

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C0680251
*Cases:* All cases had to have received diagnosis of pathologically confirmed lung cancer. Tumors from patients were classified as adenocarcinomas (AD), squamous carcinomas (SQ), large-cell carcinomas (LCC), mixed adenosquamous carcinomas (MADSQ) and other non-small cell lung cancer (NSCLC) histologies following either the International Classification of Diseases for Oncology (ICD-O) or World Health Organization (WHO) coding. Tumors with overlapping histologies were classified as mixed.
Description

Elig.phs000876.v2.p1.1

Data type

boolean

Alias
UMLS CUI [1,1]
C1706256
UMLS CUI [1,2]
C1512693
UMLS CUI [1,3]
C0243161
UMLS CUI [1,4]
C0679557
UMLS CUI [1,5]
C0242379
UMLS CUI [1,6]
C0001418
UMLS CUI [1,7]
C0007137
UMLS CUI [1,8]
C0206704
UMLS CUI [1,9]
C0206623
UMLS CUI [1,10]
C0007131
Tumors from patients were classified as adenocarcinomas (AD), squamous carcinomas (SQ), large-cell carcinomas (LCC), mixed adenosquamous carcinomas (MADSQ) and other non-small cell lung cancer (NSCLC) histologies following either the International Classification of Diseases for Oncology (ICD-O) or World Health Organization (WHO) coding. Tumors with overlapping histologies classified as mixed. All cases and controls were reported to be European ancestry. During PLINK analysis, cases or controls that clustered more than 6 standard deviations from the centroid of the population were removed.
Description

Elig.phs000876.v2.p1.2

Data type

boolean

Alias
UMLS CUI [1,1]
C1257905
UMLS CUI [1,2]
C3640076
UMLS CUI [1,3]
C0871420
*Controls:*Controls were collected at each site, according to matching schemes at each site. The M.D. Anderson Cancer Site only collected ever smoking cases matched to ever smoking controls. Data on epidemiological risk factors were not available from the UK/ICR-GWAS as these originated from the 1958 birth cohort and Wellcome Trust Case Control Consortium for which data on epidemiological risk factors were not collected.
Description

Elig.phs000876.v2.p1.3

Data type

boolean

Alias
UMLS CUI [1,1]
C0009932
UMLS CUI [1,2]
C1519386
UMLS CUI [1,3]
C0150103
UMLS CUI [1,4]
C1706256
Back to the top of the page

Similar models

Eligibility Criteria

7 forms
  1. StudyEvent: SEV1
    1. Eligibility Criteria
    2. Subject ID, subject source, source subject ID, consent group, and affection status of participants with or without lung cancer and involved in the "Transdisciplinary Research into Cancer of the Lung (TRICL) - Exome Plus Targeted Sequencing" project.
    3. Subject ID, sample ID, sample source, source sample ID, study accession, and sample use variable of participants with or without lung cancer and involved in the "Transdisciplinary Research into Cancer of the Lung (TRICL) - Exome Plus Targeted Sequencing" project.
    4. Sample ID, body site where sample was obtained, analyte type, type of DNA extraction, and tumor status of sample of participants with or without lung cancer and involved in the "Transdisciplinary Research into Cancer of the Lung (TRICL) - Exome Plus Targeted Sequencing" project.
    5. Subject ID, study site, gender, case or control status, age, smoking status, ethnicity, history, and cigarette pack per years of participants with or without lung cancer and involved in the "Transdisciplinary Research into Cancer of the Lung (TRICL) - Exome Plus Targeted Sequencing" project.
    6. Subject ID, age, gender, subjects with or without lung cancer, and smoking status of participants with or without lung cancer and involved in the "Transdisciplinary Research into Cancer of the Lung (TRICL) - Affymetrix" project.
    7. Sample ID, analyte type, body site where sample was obtained, tumor status of sample, tumor subtype of samples, and source repository where subjects originate of participants with or without lung cancer and involved in the "Transdisciplinary Research into Cancer of the Lung (TRICL) - Affymetrix" project.
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Inclusion and exclusion criteria
C1512693 (UMLS CUI [1,1])
C0680251 (UMLS CUI [1,2])
Elig.phs000876.v2.p1.1
Item
*Cases:* All cases had to have received diagnosis of pathologically confirmed lung cancer. Tumors from patients were classified as adenocarcinomas (AD), squamous carcinomas (SQ), large-cell carcinomas (LCC), mixed adenosquamous carcinomas (MADSQ) and other non-small cell lung cancer (NSCLC) histologies following either the International Classification of Diseases for Oncology (ICD-O) or World Health Organization (WHO) coding. Tumors with overlapping histologies were classified as mixed.
boolean
C1706256 (UMLS CUI [1,1])
C1512693 (UMLS CUI [1,2])
C0243161 (UMLS CUI [1,3])
C0679557 (UMLS CUI [1,4])
C0242379 (UMLS CUI [1,5])
C0001418 (UMLS CUI [1,6])
C0007137 (UMLS CUI [1,7])
C0206704 (UMLS CUI [1,8])
C0206623 (UMLS CUI [1,9])
C0007131 (UMLS CUI [1,10])
Elig.phs000876.v2.p1.2
Item
Tumors from patients were classified as adenocarcinomas (AD), squamous carcinomas (SQ), large-cell carcinomas (LCC), mixed adenosquamous carcinomas (MADSQ) and other non-small cell lung cancer (NSCLC) histologies following either the International Classification of Diseases for Oncology (ICD-O) or World Health Organization (WHO) coding. Tumors with overlapping histologies classified as mixed. All cases and controls were reported to be European ancestry. During PLINK analysis, cases or controls that clustered more than 6 standard deviations from the centroid of the population were removed.
boolean
C1257905 (UMLS CUI [1,1])
C3640076 (UMLS CUI [1,2])
C0871420 (UMLS CUI [1,3])
Elig.phs000876.v2.p1.3
Item
*Controls:*Controls were collected at each site, according to matching schemes at each site. The M.D. Anderson Cancer Site only collected ever smoking cases matched to ever smoking controls. Data on epidemiological risk factors were not available from the UK/ICR-GWAS as these originated from the 1958 birth cohort and Wellcome Trust Case Control Consortium for which data on epidemiological risk factors were not collected.
boolean
C0009932 (UMLS CUI [1,1])
C1519386 (UMLS CUI [1,2])
C0150103 (UMLS CUI [1,3])
C1706256 (UMLS CUI [1,4])
Back to the top of the page